Marco Cruciata

Dr. Marco Cruciata


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MMMartino Belvedeti Murri
Martino Belvedeti Murri
AMAngela Muscettola
Angela Muscettola
MSMichele Specchia
Michele Specchia
CMChiara Montemitro
Chiara Montemitro
LZLuigi Zerbinati
Luigi Zerbinati
MNMaria Giulia Nanni
Maria Giulia Nanni
Background: Demoralization, anxiety, irritability, and depression are common among hospital patients and are associated with poorer outcomes and greater healthcare burden. Early identification is essential, but simultaneous screening across multiple domains is often impractical with questionnaires. Computerized Adaptive Testing (CAT) offers a solution by tailoring item administration, reducing test length while preserving measurement precision. The aim of this study was to develop and validate FRIDA (Four-factor Rapid Interactive Diagnostic Assessment), a freely accessible, web-based CAT for rapid multidimensional screening of psychopathology in hospital patients. Methods: We analysed data from 472 medically ill in-patients at a University Hospital. Item calibration was performed using a four-factor graded response model (demoralization, anxiety, irritability, depression) in the mirt package. CAT simulations were run with 1000 virtual respondents to optimize item selection, exposure control, and stopping rules. The best configuration was applied to the real dataset. Criterion validity for demoralization was evaluated against the Diagnostic Criteria for Psychosomatic Research (DCPR). Results: The four-factor model showed good fit (CFI = 0.947, RMSEA = 0.080). Factor correlations were moderate to high, with the strongest overlap between demoralization and depression (r = 0.93). In simulations, the CAT required, on average, 7.8 items and recovered trait estimates with high accuracy (r = 0.94–0.97). In real patients, mean test length was 11 items, with accuracy of r = 0.95 across domains. FRIDA demonstrated good criterion validity for demoralization (AUC = 0.816; sensitivity 80%, specificity 67.5%). Conclusions: FRIDA is the first freely available, multidimensional CAT for rapid screening of psychopathology in hospital patients. It offers a scalable, efficient, and precise tool for integrating mental health assessment into routine hospital care.


7 June 2026 in Journal of Psychosomatic Research
Verified
Journal Article
Open access
RCRosangela Caruso
Rosangela Caruso
MCMarco Cruciata
Marco Cruciata
MNMaria Giulia Nanni
Maria Giulia Nanni
MMMartino Belvedeti Murri
Martino Belvedeti Murri
LZLuigi Zerbinati
Luigi Zerbinati
LGLUIGI GRASSI
LUIGI GRASSI
Depression is prevalent and clinically significant among cancer patients, being associated with poorer quality of life, treatment non-adherence, and increased mortality. However, few studies have investigated major depression and its relationship with psycho-existential dimensions using structured diagnostic tools and longitudinal designs in real-world psycho-oncology settings. This study aimed to assess the prevalence of major depression in cancer outpatients receiving integrated psycho-oncology care and to examine longitudinal changes in psychological and existential variables over six months, with a focus on baseline depression status. A total of 221 outpatients were assessed at baseline using the Patient Health Questionnaire-9. Measures included distress, anxiety, somatization, embitterment, loss of dignity, demoralization, post-traumatic growth, and traumatic stress. At six months, 156 patients completed follow-up assessments. All participants received supportive-expressive psychotherapy with elements of meaning-centered therapy and pharmacological treatment when indicated. Data were analyzed using paired t-tests and mixed models for repeated measures.. At baseline, 35.3% of patients met criteria for major depression. Depressed patients showed higher levels across all psychological and existential measures and lower post-traumatic growth. Longitudinal analyses revealed significant improvements across multiple domains, particularly among depressed patients, including embitterment and loss of dignity. Mixed-model analyses indicated significant group-by-time interactions in most variables. These findings confirm the high prevalence of major depression in cancer outpatients and its association with emotional and existential distress. Integrated psycho-oncological care was associated with meaningful psychological improvements over time, especially in patients with baseline depression, supporting the need for structured screening and tailored interventions.